Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
165.095 USD
0.26%
Updated:
Apr 19, 2024
Abbvie Inc
Net Issuance of Debt
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Net Issuance of Debt Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$-4.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
$-270m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
47%
|
CAGR 10-Years
17%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$25.7B
|
CAGR 3-Years
118%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
$-43.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
6%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Net Issuance of Debt?
Net Issuance of Debt
-4.1B
USD
-4.1B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Net Issuance of Debt amounts to -4.1B USD.
What is Abbvie Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
-21%
-21%
Over the last year, the Net Issuance of Debt growth was 67%. The average annual Net Issuance of Debt growth rates for Abbvie Inc have been -16% over the past three years , and -21% over the past ten years .
You don't have any saved screeners yet
